John G. Freund's most recent trade in SI-BONE Inc was a trade of 10,957 Common Stock done . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 10,957 | 54,258 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 34.05 per share. | 18 May 2026 | 20 | 83,952 (0%) | 0% | 34.1 | 681 | Common Stock |
| Collegium pharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 8,741 | 79,399 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | John G. Freund | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2026 | 8,700 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | John G. Freund | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.49 per share. | 14 May 2026 | 8,700 | 88,099 (0%) | 0% | 16.5 | 143,463 | Common Stock |
| Collegium pharma Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 34.54 per share. | 14 May 2026 | 4,127 | 83,972 (0%) | 0% | 34.5 | 142,547 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 15.99 per share. | 08 Aug 2025 | 12,132 | 91,767 (0%) | 0% | 16.0 | 193,998 | Common Stock |
| Collegium pharma Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 34.36 per share. | 08 Aug 2025 | 11,659 | 23,129 (0%) | 0% | 34.4 | 400,641 | Common Stock |
| Collegium pharma Inc | John G. Freund | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 15,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | John G. Freund | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.45 per share. | 09 Jun 2025 | 15,000 | 77,259 (0%) | 0% | 13.5 | 201,750 | Common Stock |
| Collegium pharma Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 30.62 per share. | 09 Jun 2025 | 6,601 | 70,658 (0%) | 0% | 30.6 | 202,149 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 8,675 | 43,301 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 9,791 | 62,259 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,791 | 34,626 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | 06 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | ||
| Collegium pharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 7,693 | 52,468 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 20.54 per share. | 09 Aug 2023 | 30,000 | 103,899 (0%) | 0% | 20.5 | 616,197 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 4,866 | 25,835 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
| Collegium pharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 9,792 | 44,775 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,324 | 20,969 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | 06 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | ||
| Collegium pharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 14,035 | 34,983 (0%) | 0% | 0 | Common Stock |